Cite
HARVARD Citation
Furmaniak, J. et al. (2022). TSH receptor specific monoclonal autoantibody K1‐70TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial. Clinical endocrinology. pp. 878-887. [Online].